NIH-funded research NIH-funded research

High-throughput DNA/RNA synthesis capability for cutting-edge nucleic acid research

Official title: Enhancing Multi-User Nucleic Acid Research Capabilities Through Acquisition of a High-Throughput Oligonucleotide Synthesizer

Funded at Carnegie-Mellon University · NIH-11420714 · Data updated 2026-11-12

A university lab is funding a high-speed DNA/RNA synthesis system to empower multiple local researchers to create custom oligonucleotides more cheaply and quickly.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCarnegie-Mellon University
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2027
Funding year2026
Award (this year)$349,500
NIH project number1S15OD042561-01
Project IDNIH-11420714 on NIH RePORTER

Who could benefit from this research

Could help

No direct patient participation; this is an infrastructure grant for research.

Less likely to help

Direct patient participation is not part of this grant.

What this research studies

This grant funds the purchase of a 24+8 position oligonucleotide synthesizer to establish in-house nucleic acid synthesis capabilities at CMU. It will support multiple CNAS and CMA research groups and expand access for the Pittsburgh research community. By enabling high-throughput, modified oligonucleotide production, it aims to accelerate projects involving antisense technologies and nucleic acid biology. The setup includes automated workflows for synthesis, cleavage, purification, and modification, reducing reliance on external vendors. The work is infrastructure-focused but directly enables future studies that could involve human disease-related nucleic acid research.

Why it matters

Potential benefit: If successful, patients could benefit indirectly through faster development of nucleic acid therapies and diagnostic tools.

How similar studies have gone: Other institutions have shown cost and time savings with in-house synthesis, though this is a novel scale for the region.

Where this research is happening

  • Carnegie-Mellon University
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Das, Subha Ranjan — Carnegie-Mellon University
  • Study coordinator: Das, Subha Ranjan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.